TY  - JOUR
AU  - Bhatt, P.
AU  - Puente Maestu, Luis
AU  - Abdulai, R.M.
PY  - 2023
DO  - 10.1056/NEJMoa2303951
UR  - https://hdl.handle.net/20.500.14352/129898
T2  - New England Journal of Medicine
AB  - BACKGROUNDIn some patients with chronic obstructive pulmonary disease (COPD), type 2 inflammationmay increase exacerbation risk and may be indicated by elevated blood eosinophilcounts. Dupilumab, a fully human monoclonal antibody, blocks the shared...
LA  - eng
M2  - 205
PB  - Massachusetts Medical Society
TI  - Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
TY  - journal article
VL  - 389
ER  -